Overview

Efficacy and Safety of Intravenous Ferric Carboxymaltose in Pediatric Patients With Iron Deficiency Anemia and Unsatisfactory Response Oral Iron Under Study Protocol 1VIT17044

Status:
Completed

Trial end date:
2021-01-29

Target enrollment:

Participant gender:

Summary

Evaluating the Efficacy and Safety of Intravenous Ferric Carboxymaltose in Pediatric Patients with Iron Deficiency Anemia and an Unsatisfactory Response to Oral Iron under Study Protocol 1VIT17044

Phase:

Phase 3

Details

Lead Sponsor:

American Regent, Inc.

Treatments:

Ferric Compounds
Iron